Severe myoclonic epilepsy in infancy: genes and variants
Explore variant evidence for Severe myoclonic epilepsy in infancy across 2 analyzed proteins (SCN1A, HCN1). Linked ClinVar records include 214 pathogenic or likely pathogenic variants, 33 variants of uncertain significance and 32 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Severe myoclonic epilepsy in infancy
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
213 ClinVar pathogenic / likely pathogenic and 62 uncertain variants in SCN1A have source records linked to Severe myoclonic epilepsy in infancy. Association strength is not clinical gene validity.
HCN1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
The protein forms a hyperpolarization-activated channel that conducts both potassium and sodium ions. It contributes to pacemaker currents and the neuronal I(h) current that shapes excitability, and HCN1 variants are associated with developmental epilepsy syndromes.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HCN1 have source records linked to Severe myoclonic epilepsy in infancy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SCN9A.
Where Severe myoclonic epilepsy in infancy variants cluster
- SCN1A I (positions 110–454): 67 of 203 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
- SCN1A S5 of repeat III (positions 1346–1369): 9 of 203 ClinVar pathogenic / likely pathogenic variants, 3.7× more than its size predicts (a length-based count, not a validated hotspot).
- SCN1A Cytoplasmic (positions 1656–1665): 5 of 203 ClinVar pathogenic / likely pathogenic variants, 5.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Severe myoclonic epilepsy in infancy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SCN1A R931H | 931 | II | Pathogenic / likely pathogenic (★★★) |
| SCN1A R1639P | 1639 | IV | Pathogenic / likely pathogenic (★★★) |
| SCN1A G908R | 908 | II | Pathogenic / likely pathogenic (★★★) |
| SCN1A V1637E | 1637 | IV | Pathogenic / likely pathogenic (★★★) |
| SCN1A P768L | 768 | II | Pathogenic / likely pathogenic (★★★) |
| SCN1A P113T | 113 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A M145T | 145 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A A1429V | 1429 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A R118S | 118 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G329C | 329 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G329V | 329 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A P358S | 358 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A V422M | 422 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A L897S | 897 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A L897F | 897 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R931L | 931 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R931P | 931 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R931S | 931 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R931C | 931 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A C959R | 959 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A C959Y | 959 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A T1658P | 1658 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A T1658M | 1658 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A A1783T | 1783 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A A1783V | 1783 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A G329A | 329 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A R393C | 393 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A P1451L | 1451 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A R1648C | 1648 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A R101Q | 101 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A A104D | 104 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A T112I | 112 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A N115K | 115 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A T162I | 162 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A K225N | 225 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A I227S | 227 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A A239T | 239 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G271V | 271 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G271S | 271 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A C277Y | 277 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A W280R | 280 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A C336Y | 336 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A A342S | 342 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A C345R | 345 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A Y349C | 349 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A D382E | 382 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A F402I | 402 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A V421M | 421 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A Y426C | 426 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A H939Y | 939 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R946P | 946 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A G950E | 950 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A G979E | 979 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A L1287P | 1287 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A I1347N | 1347 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A V1350M | 1350 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A W1358R | 1358 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A S1362R | 1362 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A G1365D | 1365 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A G1421E | 1421 | III | Pathogenic / likely pathogenic (★★) |
Showing 60 of 214.
Uncertain variants prioritized for review in Severe myoclonic epilepsy in infancy
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SCN1A R862Q | 862 | II | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R862G at the same position is pathogenic; REVEL 0.970 |
| SCN1A L221V | 221 | I | Conflicting reports (★) | +6: L221P at the same position is pathogenic; REVEL 0.936 |
| SCN1A A1440V | 1440 | III | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; A1440T at the same position is pathogenic; REVEL 0.865 |
Which prediction tools work for Severe myoclonic epilepsy in infancy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 91 out of 100
- CADD: 90 out of 100
- EVE: 90 out of 100
- MutPred: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 72 out of 100
- SpliceAI: 62 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Early-infantile DEE also has ClinVar records linked to SCN1A variants; they fall in the same places as the Severe myoclonic epilepsy in infancy variants (422 pathogenic / likely pathogenic).
- Generalized epilepsy with febrile seizures plus also has ClinVar records linked to SCN1A variants; they fall in the same places as the Severe myoclonic epilepsy in infancy variants (76 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN1A variants; they fall in the same places as the Severe myoclonic epilepsy in infancy variants (46 pathogenic / likely pathogenic).
- Familial hemiplegic migraine also has ClinVar records linked to SCN1A variants; they fall in the same places as the Severe myoclonic epilepsy in infancy variants (20 pathogenic / likely pathogenic).
- Autosomal dominant epilepsy also has ClinVar records linked to SCN1A variants; they fall in the same places as the Severe myoclonic epilepsy in infancy variants (4 pathogenic / likely pathogenic).
- Early-infantile DEE also has ClinVar records linked to HCN1 variants; they fall mostly in different places as the Severe myoclonic epilepsy in infancy variants (14 pathogenic / likely pathogenic).
- Generalized epilepsy with febrile seizures plus also has ClinVar records linked to HCN1 variants; they fall mostly in different places as the Severe myoclonic epilepsy in infancy variants (10 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to HCN1 variants; they fall mostly in different places as the Severe myoclonic epilepsy in infancy variants (8 pathogenic / likely pathogenic).
Diseases related to Severe myoclonic epilepsy in infancy
- Developmental and epileptic encephalopathy, also linked to HCN1 and SCN1A
- Early-infantile DEE, also linked to HCN1 and SCN1A
- Generalized epilepsy with febrile seizures plus, also linked to HCN1 and SCN1A
- Genetic developmental and epileptic encephalopathy, also linked to HCN1 and SCN1A
- Amyotrophic lateral sclerosis, also linked to SCN1A
- Familial hemiplegic migraine, also linked to SCN1A
- Cardiac arrhythmia, also linked to SCN1A
- Familial febrile seizures, also linked to SCN1A
- Epilepsy, also linked to SCN1A
- Autosomal dominant epilepsy, also linked to SCN1A
- Focal epilepsy, also linked to SCN1A
- Migraine, also linked to SCN1A
Frequently asked questions
Which genes have records linked to Severe myoclonic epilepsy in infancy?
This view contains 2 analyzed proteins: SCN1A, HCN1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 214 pathogenic or likely pathogenic variants, 33 variants of uncertain significance and 32 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 336 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center